Tolerability of denosumab in metastatic solid tumor patients with renal insufficiency. [electronic resource]
Producer: 20151022Description: 1657-62 p. digitalISSN:- 1433-7339
- Aged
- Aged, 80 and over
- Antibodies, Monoclonal, Humanized -- adverse effects
- Bone Density Conservation Agents -- adverse effects
- Bone Neoplasms -- secondary
- Denosumab
- Diphosphonates -- therapeutic use
- Female
- Humans
- Hypocalcemia -- chemically induced
- Hypophosphatemia -- chemically induced
- Male
- Middle Aged
- Neoplasms, Second Primary -- therapy
- Renal Insufficiency -- complications
- Retrospective Studies
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.